|
|
| Gleevec |
All Financial Data in US $ (mln) |
|
Word Search (Top 10 - by date)
|
Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets
Blueprint medicines
(May 21, 2013)
|
Endocyte Appoints Scot L. Harper, Ph.D., as Vice President of Clinical Operations
Endocyte
(May 07, 2013)
|
AB Science : 2012 Annual Financial Results and 2013 First Quarter Revenue
AB Science
(April 29, 2013)
|
Cancer Treatment Pioneers to Share America's Most Distinguished Prize in Medicine
Cancer Genetics
(April 16, 2013)
|
| ProfNet Experts Available on Pharmaceutical Patents, FBI Email Access, Energy Investments
(April 10, 2013)
|
BIND Therapeutics Appoints Gregory I. Berk, M.D. as Chief Medical Officer
BIND Therapeutics
(April 02, 2013)
|
Blueprint Medicines Announces First Collaboration with Wellcome Trust Sanger Institute and Massachusetts General Hospital Cancer Center
Blueprint medicines
(March 19, 2013)
|
Blueprint Medicines Welcomes David Schenkein, M.D., to Its Board of Directors
Blueprint medicines
(February 25, 2013)
|
Shareholders Approve All Resolutions Proposed by Novartis Board of Directors - Dr. Joerg Reinhardt to Succeed as Chairman Following Transition Period
Novartis
(February 22, 2013)
|
The Leukemia & Lymphoma Society: Impacting Blood Cancers and Beyond
Gateway
(February 19, 2013)
|
|
|
|
|
EvaluatePharma® - the premier source for pharma and biotech analysis.
Expert integration of financial and product data across historic and forecast timeframes (1986 to 2016) delivers a vast array of analytics by product, company, therapy area, EphMRA ATC code, technology, patent status (expiry date/ number), deals (upfront/ milestones), license revenues (royalties/ co-promotion) and much more.
|
|
Product Sales Summary 2009/10
|
|
Annual Sales WW - Sales
|
Growth per Year (%)
|
|
Rank1 |
Generic Name
|
Therapeutic Subcategory
|
2010 |
| Gleevec2 |
|
|
|
4,265 |
|
|
|
|
Clinical Trial Coverage: No. of Trials involving Product
|
|
|
|
Welcome
Evaluate provides market intelligence and analysis for the pharma, biotech and medtech industries.
Explore Evaluate
Partnering
EvaluatePharma® now includes Partnering Opportunities - products available for licensing.
Partnering Opportunities in EvaluatePharma® are sourced from the rights holders - all entries are verified by the team of Analysts at EvaluatePharma - and presented in their commercial context.
Register to submit your Partnering Opportunities or to see your own and other Partnering Opportunities in their commercial context with the unique industry-wide analysis in EvaluatePharma®.
Take a full subscription to see all products available for license, including updated contact details for the out-licensing entity.
Register to access more FREE content:
- 2011 Product Sales analysis
- Download analysis into Excel
- Search 2 yrs of company press releases
Register for Free Analysis
Register to access more free insights and analysis from Evaluate.
Register Now
|
|
|
|